Furusyo N - Search Results

1

Ribavirin concentration in the later stages of 48 week pegylated interferon-alpha2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response.

Furusyo N, Murata M, Ogawa E, Toyoda K, Ihara T, Ikezaki H, Hayashi T, Koga T, Kainuma M, Hayashi J. Furusyo N, et al. J Antimicrob Chemother. 2011 May;66(5):1127-39. doi: 10.1093/jac/dkr034. Epub 2011 Feb 22. J Antimicrob Chemother. 2011. PMID: 21393126

2

Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection.

Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S. Hayashi J, et al. Among authors: furusyo n. Hepatology. 1997 Mar;25(3):697-701. doi: 10.1002/hep.510250334. Hepatology. 1997. PMID: 9049221

3

Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.

Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S. Hayashi J, et al. Among authors: furusyo n. Am J Trop Med Hyg. 1997 Jan;56(1):71-5. doi: 10.4269/ajtmh.1997.56.71. Am J Trop Med Hyg. 1997. PMID: 9063365

4

Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosis.

Furusyo N, Hayashi J, Ueno K, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S. Furusyo N, et al. Clin Ther. 1997 Nov-Dec;19(6):1352-67. doi: 10.1016/s0149-2918(97)80010-0. Clin Ther. 1997. PMID: 9444445 Clinical Trial.

5

Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection.

Hayashi J, Kishihara Y, Ueno K, Yamaji K, Kawakami Y, Furusyo N, Sawayama Y, Kashiwagi S. Hayashi J, et al. Among authors: furusyo n. Arch Intern Med. 1998 Jan 26;158(2):177-81. doi: 10.1001/archinte.158.2.177. Arch Intern Med. 1998. PMID: 9448556

6

Large dose natural interferon alpha therapy for patients with chronic hepatitis C.

Ohmiya M, Hayashi J, Furusyo N, Ueno K, Kishihara Y, Nabeshima S, Kashiwagi S. Ohmiya M, et al. Among authors: furusyo n. Fukuoka Igaku Zasshi. 1997 Dec;88(12):380-8. Fukuoka Igaku Zasshi. 1997. PMID: 9465478 Clinical Trial.

7

Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus.

Hayashi J, Kawakami Y, Nabeshima A, Kishihara Y, Furusyo N, Sawayama Y, Kinukawa N, Kashiwagi S. Hayashi J, et al. Among authors: furusyo n. Dig Dis Sci. 1998 Feb;43(2):384-91. doi: 10.1023/a:1018874910195. Dig Dis Sci. 1998. PMID: 9512135

8

Hepatitis C viral RNA status at two weeks of therapy predicts the eventual response.

Yamaji K, Hayashi J, Kawakami Y, Furusyo N, Sawayama Y, Kishihara Y, Etoh Y, Kashiwagi S. Yamaji K, et al. Among authors: furusyo n. J Clin Gastroenterol. 1998 Apr;26(3):193-9. doi: 10.1097/00004836-199804000-00009. J Clin Gastroenterol. 1998. PMID: 9600368

9

Hepatitis G virus in the general population and in patients on hemodialysis.

Hayashi J, Furusyo N, Sawayama Y, Kishihara Y, Kawakami Y, Ariyama I, Etoh Y, Kashiwagi S. Hayashi J, et al. Among authors: furusyo n. Dig Dis Sci. 1998 Sep;43(9):2143-8. doi: 10.1023/a:1018883920209. Dig Dis Sci. 1998. PMID: 9753284

10

The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period.

Furusyo N, Hayashi J, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S. Furusyo N, et al. Am J Trop Med Hyg. 1998 Nov;59(5):693-8. doi: 10.4269/ajtmh.1998.59.693. Am J Trop Med Hyg. 1998. PMID: 9840583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters